EFFECT OF INJECTABLE COMBINATION ESTROGEN-PROGESTERON AND PROGESTERON-ONLY CONTRACEPTIVES ON GLUCOSE AND MALONDIALALDEHID SERUM

  • dwi retna prihati Poltekkes surakarta
  • Paryono Paryono Poltekkes Kemenkes Surakarta, Klaten, Indonesia.
  • Wiwin Rohmawati Muhammadiyah University, Klaten, Indonesia.

Abstract

Injectable hormonal contraception has been the most favorable contraception method in Indonesia in 2013 and its number reaches 4,128,115 acceptors (48.56%). The estrogen and progesterone contents in injectable contraception could cause stress, increased appetite, decreased leptin level and insulin resistance, eventually leading to increased blood glucose and serum malondialaldehyde levels. This study aims to observe the main effect of use of combined estrogen-progesteron and only progesteron injectable hormonal contraceptions on glucose level in blood and malondialaldehyde (MDA) level in serum. This is an experimental laboratory study. It uses Randomized pre-post test group research design for glucose level and randomized post test with control for malondialaldehyde level. The data are analyzed using Anova. The significance value is p<0.01. 28 samples are divided into 7 groups and each group consists of 4 samples, namely one control group and 6 treatment groups consisting of P1 combined dose 0.54 mg, P2 combined dose 1.08 mg, P3 combined dose 1.62 mg, P4 DMPA dose 2.7 mg, P5 DMPA dose 5.4 mg, P6 DMPA dose 8.1 mg.  Only DMPA contraception at 0.54 mg dose influences the blood glucose level increase by p = 0.00. Only DMPA contraception at 8.1 mg dose does not influence serum MDA level by p = 0.1. The conclusion is DMPA contraception has greater potential of causing blood glucose level increase than the combined contraception. Combined and DMPA contraceptions share the risk of increasing serum MDA level.

Downloads

Download data is not yet available.

References

Baziad Ali, 2002. Kontrasepsi Hormonal. Jakarta: Yayasan Bina Pustaka

Bergman RN, Ader M, 2000. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab. 11:351–356

Bild D, Jacobs D, Liu K, Williams O, Hilner J, Perkins L, Marcovina S, Hulley S, 1996. Seven-year trends in plasma low-density lipoprotein-cholesterol in young adults: the cardia study. Ann Epidemiol 6:235–245

Brownlee, M., 2001. Biochemistry and molecular cell biology of diabetic complications. Nature. 414:813–20.

Crook D, 1997. Multicenter study of endocrine function and plasma lipids and lipoproteins in women using oral contraceptives containing desogestrel progestin. Contraception. 55:219–224

Dawn B. Marks, Allan D. Marks, Collen Smit M., 2000. Biokimia Kedokteran Dasar. Jakarta: EGC. pg 321-358

Friedman G, Cutter G, Donahue R, Hughes G, Hulley S, Jacobs D, Liu K, Savage P: cardia ,1988. Study design, recruitmen, and some characteristics of the examined subjects. J Clin Epidemiol 41:1105–1116

González, C., A. Alonso, N.A. Grueso, F. Díaz, M.M. Esteban, S. Fernández, and A.M. Patterson, 2002. Role of 17 β-estradiol administration on insulin sensitivity in the rat: Implications for the insulin receptor. Steroids 67: 993–1005.

Haffner S, Bowsher R, Mykkanen L, Hazuda H, Mitchell B, Valdez R, Gingerich R, Monterossa A, Stern M., 1994. Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM. Diabetes 43:1490–1493

Hartanto H., 2010. KB dan Kontrasepsi. Jakarta: Pustaka Sinar Harapan

Hill J, Sidney S, Lewis C, Tolan K, Scherzinger A, Stamm E., 1999. Racial differences in amounts of visceral adipose tissue in young adults: the cardia (Coronary Artery Risk Development in Young Adults) study.Am J Clin Nutr 69:381–387

Irianto K., 2014. Pelayanan Keluarga Berencana Dua anak Cukup. Bandung: Alfabeta

Jacobs D, Hahn L, Haskell W, Pirie P, Sidney S., 1989. Validity and reliability of short physical activity history: cardia Study and the Minnesota Heart Health Program. J Cardiopulm Rehab 9:448–459

Kementrian Kesehatan Republik Indonesia, 2014. Situasi dan analisis keluarga berencana. www.pusdatin.kemkes.go.id

Limanan, D., Prijanti, A.R, 2013. Hantaran Sinyal Leptin dan Obesitas: Hubungannya dengan penyakit Kardiovaskular. eJKI, 1, 149-156

Myers MG Jr., 2004. Leptin receptor signaling and the regulation of mammalian physiology. Recent ProgHorm Res. 59:287–304.

Nadal, A., J.M. Rovira, O. Laribi, T. León-Quinto, E. Andreu, C. Ripoll, and B. Soria, 1998. Rapid insulinotropic effect of 17β-estradiol via a plasma membrane receptor. The FASEB Journal 12: 1341–8.

Norris, C.W., 2013. Why NFP. The Linacre Quarterly 80: 218–21

Patiño, V.M., B. Díaz-Toledo, and P.G. del Barrio., 2008. Anticoncepción en la Mujer con Diabetes. Avances en Diabetología 24:205–9.

Pouliot MC, Despres JP, Nadeau A, Tremblay A, Moorjani S, Lupien PJ, Theriault G, Bouchard C., 1990. Associations between regional body fat distribution, fasting plasma free fatty acid levels, and glucose tolerance in premenopausal women. Int J Obes 14:293–302

Robert K. Murray, 2006. Sel Darah Merah Dan Putih Dalam Buku Biokimia Harper edisi 27 . Jakarta: EGC. hal 636-652

Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H., 2003. Glucose toxicity in beta-cells: type 2 diabetes, suitable radicals have gone bad, and the glutathione connection. Diabetes. 52:581–7.

Robertson RP, Harmon J, Tran PO, Poitou V., 2004. β-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes. 53:S119–24.

Sitruk-Ware, R. and Nath A., 2013. Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills. Best Practice & Research: Clinical Endocrinology & Metabolism 27: 13–24

Skouby, S.O., K.R. Petersen, and J. Jespersen, 1996. Screening for disturbances in glucose metabolism: Can it prevent cardiovascular disease in pill users? In Evidence-guided prescribing of the pill, ed. PC, Hannaford and AMC Webb, 99–108. London: Parthenon Publishing.

Takahashi H, Tran PO, LeRoy E, Harmon JS, Tanaka Y, Robertson RP., 2004. d-Glyceraldehyde causes the production of intracellular peroxide in pancreatic islets, oxidative stress, and defective-cell function via non-mitochondrial pathways. J Biol Chem. 279:37316–23

Thibodeau, P.A., Kachadourian, R., Lemay, R., Bisson, M., Day, B.J. and Paquette, B., 2002. In Vitro Pro- and Antioxidant Properties of Estrogens. Journal of Steroid Biochemistry and Molecular Biology. 81: 227-236.

Wagenknecht L, Craven T, Preisser J, Manolio T, Winders S, Hulley S., 1998. Ten-year trends in cigarette smoking among young adults, 1986–1996: the CARDIA study: Coronary Artery Risk Development in Young Adults. Ann Epidemiol 8:301–307

Wilopo SA., 2006. Perkembangan Teknologi Kontrasepsi Terkini : Implikasinya pada program KB dan Kesehatan Reproduksi di Indonesia. FK UGM Yogyakarta

World Health Organization, 2000. Improving access to quality care in family planning. Medical eligibility criteria for contraceptive use (article online). Available from http://www.who.int/reproductivehealth/publications/RHR_00_2_medical_eligibility_criteria_second_edition/index.

Published
2020-08-29
How to Cite
prihati, dwi, Paryono, P., & Rohmawati, W. (2020). EFFECT OF INJECTABLE COMBINATION ESTROGEN-PROGESTERON AND PROGESTERON-ONLY CONTRACEPTIVES ON GLUCOSE AND MALONDIALALDEHID SERUM. INTERNATIONAL JOURNAL OF NURSING AND MIDWIFERY SCIENCE (IJNMS), 4(2), 99-104. https://doi.org/10.29082/IJNMS/2020/Vol4/Iss2/281